Overview

Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy

Status:
Not yet recruiting

Trial end date:
2024-09-30

Target enrollment:

Participant gender:

Summary

The goal of this multicenter, double-blind, randomized controlled clinical trial is to compare the effect of intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. The main question it aims to answer are whether intravenous lidocaine reduce postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. Participants will be given intravenous lidocaine infusion in lidocaine group or placebo in control group.

Phase:

N/A

Details

Lead Sponsor:

Sichuan Cancer Hospital and Research Institute

Treatments:

Lidocaine